Esta página foi traduzida automaticamente e a precisão da tradução não é garantida. Por favor, consulte o versão em inglês para um texto fonte.

Artificial Intelligence Versus Clinical Examination in White Spot Lesions Detection, Identification, And Scoring

8 de junho de 2026 atualizado por: Mohamed Hisham Abd ElFattah Gabr Ali, Cairo University

Diagnostic Accuracy of Artificial Intelligence Analysis Using Intraoral Photographs Versus Clinical Examination in White Spot Lesions Detection, Identification, And Scoring.

The goal of this observational study is to compare the diagnostic accuracy of Clinical examination as a standard for detection, identification and scoring of White Spot Lesions Versus Artificial intelligence analysis of intraoral photographs. The photographs are examined by experienced dental professionals to maintain diagnostic accuracy. Machine learning models YOLO and Mask-RCNN will analyze these images in three phases: pre-analytical, analytical and post-analytical. A dataset of 329 labelled photographs, annotated by experts, is used to train these models. Data augmentation methods enhance model performance, and accuracy is assessed against clinical examination results to confirm reliability.

The main question it aims to answer is:

- Is artificial intelligence analysis of intraoral photographs as accurate as clinical assessment in the detection, identification, and scoring of white spot lesions among adult Egyptian patients attending Cairo University Dental Hospital?

Visão geral do estudo

Status

Ainda não está recrutando

Descrição detalhada

Dentists frequently encounter various dental hard tissue anomalies that present both diagnostic challenges and require careful treatment planning. A common example is white spot lesions or whitish discolorations of the teeth that can arise from multiple etiologies. These may be carious in nature, such as post-orthodontic incipient caries, or represent developmental defects like dental fluorosis or molar-incisor hypo-mineralization (MIH). Distinguishing between these conditions is essential for appropriate clinical management. The diagnosis of WSLs primarily relies on visual and photographic examination, which evaluates the morphology, size, color, and location of the lesions. Depth assessment is particularly critical, as it serves as a key determinant in selecting the most appropriate treatment approach. Detection and scoring of WSLs can be accomplished through clinical visual inspection alone or enhanced by adjunctive diagnostic technologies, including laser fluorescence, quantitative light-induced fluorescence (QLF), and electrical impedance spectroscopy.

The clinical characteristics of WSLs can vary considerably, making differential diagnosis challenging. While specialist clinicians demonstrate high validity and reliability in distinguishing between various white spot lesions, general dental practitioners exhibit lower diagnostic accuracy. Conventional diagnostic approaches for white spot lesions often lack precision and consistency. Visual assessment presents several inherent limitations, including the potential for misclassification due to overlapping clinical presentations among different etiologies. A systematic review and meta-analysis examining the efficacy of detection methods for incipient caries reported that photographic visual inspection achieved a sensitivity of only 67% and specificity of 79%, highlighting the need for more reliable diagnostic approaches.

Recent advances in computing power, data accessibility, and processing capabilities have accelerated the development of artificial intelligence (AI) applications, transforming contemporary healthcare research. Dentistry has similarly benefited from this technological evolution, with AI demonstrating considerable potential across various clinical applications. Machine learning (ML), a subfield of AI, represents a powerful approach for computer-aided diagnostic support, with algorithms that identify patterns within datasets during training and apply this knowledge to make predictions on new data. Emerging evidence indicates that these AI advances can improve diagnostic accuracy in caries detection, thereby supporting clinicians in making more precise and reliable assessments. Dental photography, captured using devices such as DSLR cameras or intraoral cameras, serves as a valuable tool for diagnosis and treatment planning. When combined with intelligent image analysis methods, AI can automate the identification and assessment of diagnostic data from photographs, facilitating standalone diagnostic procedures that reduce subjectivity and enhance clinical decision-making. Deep CNNs can detect and distinguish entities of similar but not identical appearance when trained on sufficiently large image datasets. Employing such models as part of an integrated image-analysis software solution would enable rapid classification of existing photographic library data and improve the accuracy and reliability of clinicians' decision-making in treatment planning or referral. Emerging evidence from studies using intraoral photographs and AI algorithms demonstrates promising detection rates, with AI exhibiting high sensitivity, specificity, precision, accuracy, and reliability in diagnostic performance. AI-driven tools are designed to serve as supportive aids for clinicians, strengthening diagnostic accuracy, streamlining workflows, improving cost-efficiency, and enhancing patient care rather than replacing clinical expertise. Simplifying the diagnostic process for white spot lesions is essential to enable their timely detection at an early stage, facilitating prompt intervention and improving preventive outcomes. AI models must be validated using local data from diverse clinical settings, particularly in lower-middle-income countries, with their performance assessed through sensitivity, specificity, and accuracy measures and benchmarked against conventional diagnostic approaches. Therefore, it is crucial to develop and validate white spot lesion detection and classification models using data from Egyptian patients attending Cairo University Hospital to ensure accurate and clinically relevant results, emphasizing the potential improvements in accuracy and reliability that AI can bring to dental diagnostics.

Tipo de estudo

Observacional

Inscrição (Estimado)

329

Contactos e Locais

Esta seção fornece os detalhes de contato para aqueles que conduzem o estudo e informações sobre onde este estudo está sendo realizado.

Contato de estudo

Critérios de participação

Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.

Critérios de elegibilidade

Idades elegíveis para estudo

  • Adulto

Aceita Voluntários Saudáveis

Não

Método de amostragem

Amostra Não Probabilística

População do estudo

Patients attending the Conservative Department of Cairo University Dental Clinic, aged from 20 to 60 years, presenting with white spot lesions of teeth, showing no signs or symptoms, demonstrating co-operation, and expressing interest in participating in the study will be considered eligible. Patients with orthodontic appliances or bridgework that could impact the clinical assessment process will be excluded.

Descrição

Inclusion Criteria:

  1. Adult patients aged 20 - 60 years
  2. Males or Females
  3. Patients with white spot lesions of teeth 4 - Co-operative patients with interest in participation in the study

Exclusion Criteria:

  1. Patients with orthodontic appliances or bridgework that might interfere with evaluation and assessment
  2. Patients with no white spot lesions
  3. Patients with systematic diseases that might affect participation
  4. Patients refusing to sign the informed consent or not willing to be part of the study

Plano de estudo

Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.

Como o estudo é projetado?

Detalhes do projeto

O que o estudo está medindo?

Medidas de resultados primários

Medida de resultado
Prazo
Artificial Intelligence diagnostic accuracy in White Spot Lesions Detection
Prazo: Baseline
Baseline

Colaboradores e Investigadores

É aqui que você encontrará pessoas e organizações envolvidas com este estudo.

Patrocinador

Investigadores

  • Diretor de estudo: Asmaa A. Mohamed Yassen, Professor of Conservative Dentistry Department, Faculty of Dentistry, Cairo University
  • Diretor de estudo: Rawda Hesham Abdelaziz, Associate Professor of Conservative Dentistry Department, Faculty of Dentistry, Cairo University
  • Diretor de estudo: Asmaa A. Elsayed Osman, Lecturer of Information Technology, Faculty of Computers and Artificial Intelligence, Cairo University

Publicações e links úteis

A pessoa responsável por inserir informações sobre o estudo fornece voluntariamente essas publicações. Estes podem ser sobre qualquer coisa relacionada ao estudo.

Datas de registro do estudo

Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados ​​pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.

Datas Principais do Estudo

Início do estudo (Estimado)

1 de julho de 2026

Conclusão Primária (Estimado)

1 de julho de 2027

Conclusão do estudo (Estimado)

1 de novembro de 2027

Datas de inscrição no estudo

Enviado pela primeira vez

2 de junho de 2026

Enviado pela primeira vez que atendeu aos critérios de CQ

8 de junho de 2026

Primeira postagem (Real)

10 de junho de 2026

Atualizações de registro de estudo

Última Atualização Postada (Real)

10 de junho de 2026

Última atualização enviada que atendeu aos critérios de controle de qualidade

8 de junho de 2026

Última verificação

1 de junho de 2026

Mais Informações

Termos relacionados a este estudo

Outros números de identificação do estudo

  • AI in detecting dental caries

Plano para dados de participantes individuais (IPD)

Planeja compartilhar dados de participantes individuais (IPD)?

INDECISO

Informações sobre medicamentos e dispositivos, documentos de estudo

Estuda um medicamento regulamentado pela FDA dos EUA

Não

Estuda um produto de dispositivo regulamentado pela FDA dos EUA

Não

Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .

Ensaios clínicos em Artificial Intelligence models (YOLO and MASK-RCNN)

Se inscrever